Daniel Menold's most recent trade in Cymabay Therapeutics Inc was a trade of 10,000 Common Stock done at an average price of $23.6 . Disclosure was reported to the exchange on Jan. 16, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cymabay Therapeutics Inc | Daniel Menold | Vice President, Finance | Sale of securities on an exchange or to another person at price $ 23.58 per share. | 16 Jan 2024 | 10,000 | 0 (0%) | 0% | 23.6 | 235,806 | Common Stock |
| Cymabay Therapeutics Inc | Daniel Menold | Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.05 per share. | 16 Jan 2024 | 10,000 | 10,000 (0%) | 0% | 4.1 | 40,500 | Common Stock |
| Cymabay Therapeutics Inc | Menold Daniel | Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2024 | 10,000 | 135,109 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Daniel Menold | Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.43 per share. | 15 Dec 2023 | 11,497 | 11,497 (0%) | 0% | 8.4 | 96,920 | Common Stock |
| Cymabay Therapeutics Inc | Daniel Menold | Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 11,497 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Daniel Menold | Vice President, Finance | Sale of securities on an exchange or to another person at price $ 21.99 per share. | 15 Dec 2023 | 11,497 | 0 (0%) | 0% | 22.0 | 252,799 | Common Stock |
| Cymabay Therapeutics Inc | Menold Daniel | Vice President, Finance | Sale of securities on an exchange or to another person at price $ 21.98 per share. | 15 Dec 2023 | 10,000 | 0 (0%) | 0% | 22.0 | 219,847 | Common Stock |
| Cymabay Therapeutics Inc | Daniel Menold | Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 10,000 | 145,109 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Daniel Menold | Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.05 per share. | 15 Dec 2023 | 10,000 | 10,000 (0%) | 0% | 4.1 | 40,500 | Common Stock |
| Cymabay Therapeutics Inc | Daniel Menold | Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 15 Aug 2023 | 8,500 | 8,500 (0%) | 0% | 1.1 | 9,010 | Common Stock |
| Cymabay Therapeutics Inc | Daniel Menold | Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 8,500 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Daniel Menold | Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. | 15 Aug 2023 | 7,000 | 7,000 (0%) | 0% | 10 | 70,000 | Common Stock |
| Cymabay Therapeutics Inc | Daniel Menold | Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 7,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Daniel Menold | Vice President, Finance | Sale of securities on an exchange or to another person at price $ 12.35 per share. | 09 Aug 2023 | 20,945 | 0 (0%) | 0% | 12.4 | 258,744 | Common Stock |
| Cymabay Therapeutics Inc | Daniel Menold | Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.00 per share. | 09 Aug 2023 | 20,945 | 20,945 (0%) | 0% | 5 | 104,725 | Common Stock |
| Cymabay Therapeutics Inc | Daniel Menold | Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2023 | 14,459 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Daniel Menold | Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2023 | 6,486 | 0 | - | - | Stock Appreciation Right | |
| Cymabay Therapeutics Inc | Daniel Menold | Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Daniel Menold | Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Daniel Menold | Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 42,000 | 42,000 | - | - | Employee Stock Option (right to buy) |